Patents by Inventor Lori A. Charie

Lori A. Charie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8663935
    Abstract: Novel compositions containing (i) ligand conjugated phycobiliprotein tandem dyes and (ii) unconjugated phycobiliproteins are provided wherein the phycobiliproteins are derived from the same bacterial or eukaryotic algae species. The phycobiliproteins must be the same or different, but must contain some non-crosslinked subunits which exchange. Also provided are methods for preparing these compositions, kits containing these compositions or components of the same, and methods of using these compositions for cellular and non-cellular analysis.
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: March 4, 2014
    Assignee: Beckman Coulter, Inc.
    Inventors: Joseph Wolfers, Fabrice Malergue, Ravinder K. Gupta, Lori A. Charie, Francisco Estevez-Labori, Meryl Forman, Emmanuel Gautherot
  • Publication number: 20100151493
    Abstract: Novel compositions containing (i) ligand conjugated phycobiliprotein tandem dyes and (ii) unconjugated phycobiliproteins are provided wherein the phycobiliproteins are derived from the same bacterial or eukaryotic algae species. The phycobiliproteins must be the same or different, but must contain some non-crosslinked subunits which exchange. Also provided are methods for preparing these compositions, kits containing these compositions or components of the same, and methods of using these compositions for cellular and non-cellular analysis.
    Type: Application
    Filed: December 10, 2009
    Publication date: June 17, 2010
    Applicant: Beckman Coulter, Inc.
    Inventors: Joseph Wolfers, Fabrice Malergue, Ravinder K. Gupta, Lori A. Charie, Francisco Estevez-Labori, Meryl Forman, Emmanuel Gautherot
  • Patent number: 6913932
    Abstract: A stabilization reagent composition, particularly desirable for stabilizing blood samples containing platelets, contains reactants that generate multiple species of formaldehyde-ammonium complexes; at least one inhibitor of phosphatase enzymatic activity; and at least one inhibitor of protease enzymatic activity. Blood samples and other tissues are stabilized by this composition. Such stabilized samples are produced by methods for stabilizing the tissue by contacting the sample with the composition.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: July 5, 2005
    Assignee: Beckman Coulter, Inc.
    Inventors: John A. Maples, Lori A. Charie, Daniel James Flagler, Rhonda Ann Mills, Richard Timmons
  • Patent number: 5164293
    Abstract: A hybrid cell line is provided which is capable of producing monoclonal antibodies which binds to HTLV-I and HTLV-II core antigens p24 and p53; but does not bind the p19 core antigen. The antibody also binds to core antigens of simian T-cell leukemia virus Type I (STLV-I). The monoclonal antibody is identified as the KC-88 monoclonal antibody. The cell line which produces the KC-88 monoclonal antibody has been deposited in the American Type Culture Collection, Rockville, Md. and assigned A.T.C.C. Deposit No. HB 10562.
    Type: Grant
    Filed: September 25, 1990
    Date of Patent: November 17, 1992
    Assignee: Coulter Corporation
    Inventors: David E. Hofheinz, Gary P. Toedter, Lori A. Charie, Samuel R. Pearlman